喜报：南模生物获批成为2024年第一批大企业开放创新中心成员
在2024年5月20日浦东新区科技节开幕式上，南模生物开放创新中心入选2024年首批大企业开放创新中心（GOI）名单。
大企业开放创新中心计划（GOI）是浦东推动大企业携手创新企业共同成长的有力机制。自2021年7月正式发布以来，浦东深化推进GOI，充分发挥龙头科技企业集聚的优势，鼓励大企业投身浦东创业孵化，链接带动科技型中小微企业创新发展，打造“政产学研金服用”七位一体的创新“热带雨林”。
南模生物开放创新中心将依托自身丰富的模式生物资源、比较医学研究技术平台、基于CRISPR基因编辑和体内潜在药靶发现技术，赋能国内外优质生命科学研究单位和生物医药创新企业，打通新药研发的“最初一公里”，加速从人类基因组中发掘潜在药物靶点和靶向药物的进程，为我国生物医药产业发展提供创新源头。
你也可能感兴趣
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
